Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

RPRX – Royalty Pharma plc

RPRX — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

3.35

Margin Of Safety %

-19

Put/Call OI Ratio

0.21

EPS Next Q Diff

0.6

EPS Last/This Y

3.33

EPS This/Next Y

0.5

Price

53.06

Target Price

59.57

Analyst Recom

1.5

Performance Q

17.62

Upside

-20.8%

Beta

0.4

Ticker: RPRX




21 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-21RPRX49.490.230.368988
2026-04-23RPRX49.650.233.009046
2026-04-24RPRX49.380.230.009049
2026-04-27RPRX49.650.230.369054
2026-04-28RPRX49.540.230.009087
2026-04-29RPRX49.490.230.009078
2026-04-30RPRX50.10.230.119078
2026-05-01RPRX49.450.230.009067
2026-05-04RPRX50.190.230.069076
2026-05-05RPRX50.470.230.009084
2026-05-06RPRX50.70.220.159361
2026-05-07RPRX50.20.220.589371
2026-05-08RPRX50.810.230.099521
2026-05-11RPRX51.640.230.009646
2026-05-12RPRX51.690.180.0011460
2026-05-13RPRX53.270.180.0011540
2026-05-14RPRX53.370.190.0011213
2026-05-15RPRX52.820.200.0010727
2026-05-18RPRX52.060.210.0010014
2026-05-19RPRX52.40.210.0110015
2026-05-20RPRX53.060.210.009903
DateSymbolLatestP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-21RPRX49.4914.7137.35.10
2026-04-22RPRX49.7114.7138.25.10
2026-04-23RPRX49.6314.7130.05.10
2026-04-24RPRX49.3812.1125.35.10
2026-04-27RPRX49.6512.1139.35.10
2026-04-28RPRX49.5412.1129.25.10
2026-04-30RPRX50.1012.1148.25.10
2026-05-01RPRX49.4512.1115.05.10
2026-05-04RPRX50.2012.1152.45.10
2026-05-05RPRX50.4712.1139.15.10
2026-05-06RPRX50.6812.1137.75.10
2026-05-07RPRX50.2112.1112.45.10
2026-05-08RPRX50.8012.185.65.08
2026-05-11RPRX51.6412.0-169.35.08
2026-05-12RPRX51.6911.8-187.15.12
2026-05-13RPRX53.2511.8-154.05.12
2026-05-14RPRX53.3711.8-185.85.12
2026-05-15RPRX52.8111.8-195.25.12
2026-05-18RPRX52.0711.8-200.15.12
2026-05-19RPRX52.4011.8-175.85.12
2026-05-20RPRX53.0611.8-174.05.12
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-21RPRX-3.193.852.90
2026-04-22RPRX-3.193.852.90
2026-04-23RPRX-3.213.852.90
2026-04-24RPRX-3.213.852.90
2026-04-27RPRX-3.133.542.92
2026-04-28RPRX-3.133.542.92
2026-04-29RPRX-3.213.542.92
2026-04-30RPRX-3.213.542.92
2026-05-01RPRX-3.293.542.92
2026-05-04RPRX-3.293.302.92
2026-05-05RPRX-3.293.302.92
2026-05-06RPRX-3.293.302.92
2026-05-07RPRX-3.293.302.92
2026-05-08RPRX-3.293.302.92
2026-05-11RPRX-3.294.002.92
2026-05-12RPRX-3.304.003.35
2026-05-13RPRX-3.304.003.35
2026-05-14RPRX-3.304.003.35
2026-05-15RPRX-3.304.003.36
2026-05-18RPRX-3.343.973.35
2026-05-19RPRX-3.433.973.35
2026-05-20RPRX-3.283.973.35
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

0.53

Avg. EPS Est. Current Quarter

1.27

Avg. EPS Est. Next Quarter

1.13

Insider Transactions

-3.28

Institutional Transactions

3.97

Beta

0.4

Average Sales Estimate Current Quarter

805

Average Sales Estimate Next Quarter

872

Fair Value

43.21

Quality Score

64

Growth Score

69

Sentiment Score

93

Actual DrawDown %

0.8

Max Drawdown 5-Year %

-43.4

Target Price

59.57

P/E

27.79

Forward P/E

9.44

PEG

1.03

P/S

12.52

P/B

3.42

P/Free Cash Flow

11.22

EPS

1.91

Average EPS Est. Cur. Y​

5.12

EPS Next Y. (Est.)

5.61

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

33.89

Relative Volume

0.85

Return on Equity vs Sector %

-15

Return on Equity vs Industry %

0.5

EPS 1 7Days Diff

EPS 1 30Days Diff

0.06

EBIT Estimation

-174
RPRX Healthcare
$53.06
📉
Swing / Pullback
Buy the dip on strong trends
51 /100
WEAK
Trend
20/20
Pullback
6/25
Volume
7/15
Valuation
7/20
TP/AR
4/10
Options
7/10
RSI
67.8
Range 1M
95.2%
Sup Dist
2.1%
🚀
Momentum Growth
Ride accelerating trends
N/A
49 /100
WEAK
Momentum
14/25
Growth
14/30
Estimates
6/20
Inst/Vol
7/15
Options
8/10
EPS Yr
6.2%
EPS NY
9.6%
52W%
99%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +63.2% upside
Quality
6/30
Valuation
16/30
Growth
9/25
Stability
6/10
LT Trend
4/5
Upside
+63.2%
Quality
64
MoS
-19%
Royalty Pharma plc
Sector: Healthcare
Industry: Biotechnology
Employees: 100
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.
RPRX

Latest News

Caricamento notizie per RPRX
stock quote shares RPRX – Royalty Pharma plc Stock Price stock today
news today RPRX – Royalty Pharma plc stock forecast ,stock prediction 2023 2024 2025
marketwatch RPRX – Royalty Pharma plc yahoo finance google finance
stock history RPRX – Royalty Pharma plc invest stock market
stock prices RPRX premarket after hours
ticker RPRX fair value insiders trading